Navigation Links
Final space shuttle to carry 5 CU-Boulder-built payloads
Date:7/5/2011

The University of Colorado Boulder is involved with five different space science payloads ranging from antibody tests that may lead to new bone-loss treatments to an experiment to improve vaccine effectiveness for combating salmonella when Atlantis thunders skyward July 8 on the last of NASA's 135 space shuttle missions.

One experiment, sponsored by the global pharmaceutical companies Amgen and UCB, will test an antibody to sclerostin -- a protein that has a negative effect on bone formation, mass and strength -- on lab mice flying on the shuttle. Researchers on the project hope the sclerostin antibody treatment will inhibit the action of sclerostin.

The research team hopes the findings may lead to potential therapeutic treatments for astronauts, who suffer significant bone loss during spaceflight, especially on long-term missions. They also might provide insight for future research in the prevention and treatment of skeletal fragility that may be caused by stroke, cerebral palsy, muscular dystrophy, spinal cord injury and reduced physical activity. Amgen is headquartered in Thousand Oaks, Calif., while UCB is headquartered in Brussels, Belgium.

There are seven co-principal investigators on the sclerostin antibody experiment, including Louis Stodieck, director of CU-Boulder's BioServe Space Technologies and a faculty member in the aerospace engineering sciences department. The research team includes a second CU-Boulder co-principal investigator, Assistant Professor Virginia Ferguson of mechanical engineering, an expert in biomaterials, including bone.

A second payload, called the Recombinant Attenuated Salmonella Vaccine, or RASV, will allow scientists to search for novel gene targets for vaccine development and improvement using the low gravity of space. The principal investigator on the experiment is Associate Professor Cheryl Nickerson of Arizona State University.

The RASV experiment will be carried aboard
'/>"/>

Contact: Louis Stodieck
stodieck@colorado.edu
303-492-4010
University of Colorado at Boulder
Source:Eurekalert  

Page: 1 2 3 4

Related biology news :

1. Finalists announced in the Elsevier Grand Challenge
2. Substantial work ahead for water issues, say scientists at ACS Final Report briefing
3. Final frontier: Mission to explore buried ancient Antarctic lake given green light
4. Aware, Inc. Announces Final Results of Dutch Auction Tender Offer
5. Cements basic molecular structure finally decoded
6. TGen finalizes alliance with Van Andel Research Institute
7. Finally, an excuse for pregnant women to eat bacon and eggs
8. Final moments of bee landing tactics revealed
9. U of Minnesota finalizes license agreement to form start-up company based on Doris Taylor research
10. Scientists discover final piece in phytate jigsaw
11. Final flight of space shuttle Discovery to carry 2 payloads built by CU-Boulder
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Final space shuttle to carry 5 CU-Boulder-built payloads
(Date:1/22/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) a ... the recent success of the Wocket™ smart wallet at CES 2015 in ... was named as one of the "11 Hot Products at CES" in ... At CES So Far" by Newseveryday.com and "The top 10 gadgets from ...
(Date:1/22/2015)... , Europe,s most prestigious innovation ... to present a video retrospective of the most exciting and innovative ... Toumazou and Sophie Wilson   A different ...   Starting on 22 January 2015 on   http://www.epo.org/european-inventor   ...
(Date:1/22/2015)... Infinisource has launched its new NXG series of time clocks ... a higher standard for collecting attendance and labor data and ... installation, touch screen interface and seamless connection to cloud-based iSolved, ... solution for the small to mid-size employer. The ...
Breaking Biology News(10 mins):CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3Infinisource's NXG series sets new time clock standard 2
... Female harbor seal pups whose blubber falls below average levels ... death, even if they get enough fat in their diets ... American Physiological Society and presented at Experimental Biology 2006. , ... when captured from the wild continued to gain weight and ...
... transplantation performed in France spread around the world, plastic ... first full facial transplantation a reality. , In the ... surgeons demonstrated how to successfully complete a full facial ... the March issue of Plastic and Reconstructive Surgery® (PRS), ...
... likely to have poor outcomes following a living-donor liver ... dye was eliminated by the liver shortly after surgery ... a reliable indicator of the outcome of the procedure. ... the dye, making it particularly useful in treating transplant ...
Cached Biology News:Alaska seal pup diet may hold key to decline of population 2Alaska seal pup diet may hold key to decline of population 3Alaska seal pup diet may hold key to decline of population 4Plastic surgeons countdown first full facial transplantation 2Predicting successful outcomes in living-donor liver transplants 2Predicting successful outcomes in living-donor liver transplants 3
(Date:2/27/2015)... GERMANTOWN, Md. and SUMMERLAND, British ... Corporation (NYSE: XON ), a leader ... an agreement to acquire  Okanagan Specialty Fruits (OSF), ... apple , the world,s first non-browning apple. Through ... trees yielding fruit that is more appetizing and convenient ...
(Date:2/27/2015)... DUBLIN , Feb. 27, 2015 Research and Markets ... the "Global Market Report of Trypsin" report to ... Trypsin (CAS 9002-07-7) aims at providing comprehensive data on Trypsin ... Asia , North America , ... trends, pays close attention to Trypsin This report ...
(Date:2/27/2015)... , Feb. 27, 2015 Bionomics Limited (ASX:BNO, ... DisrupTOR-1 trial of BNC105 in patients with metastatic renal ... Orlando, Florida . The data will be ... City of Hope Comprehensive Cancer Center in ... The new data identifies Ferritin and IL-8 as ...
(Date:2/27/2015)... Cytokinetics, Incorporated (Nasdaq: CYTK) announced today ... patients and health care advocates in the United States ... Rare Disease Day is dedicated to elevating public ... special challenges faced by patients with rare diseases and ... to stand alongside patients and caregivers representing the rare ...
Breaking Biology Technology:Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4Global Market Report of Trypsin 2014-2018 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6
... million in 2008 on target; Potential label ... expansion could further drive sales, ... CTIC) reported financial results for the quarter,ended June 30, 2008. ... for the second quarter of 2007 due primarily to sales,of ...
... Aug. 15 XTL,Biopharmaceuticals Ltd. (Nasdaq: XTLB ... Staff Deficiency Letter from The Nasdaq Stock Market,("Nasdaq") ... the audit,committee composition requirements of Nasdaq Marketplace Rule ... comprised of at least,three independent directors., XTL, ...
... Increases 34% Driving Record Profitability, HARBIN, China, ... (the "Company") (OTC Bulletin Board: CKGT), a,vertically integrated ... cactus-based consumer products in China, announced today record,second ... 2008. The Company,reported revenue of $5.0 million, a ...
Cached Biology Technology:Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results 2Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results 3Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results 4Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results 5Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results 6Cell Therapeutics, Inc.'s Second Quarter 2008 Financial Results 7XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition 2XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition 3China Kangtai Cactus Biotech Announces Record Second Quarter Results 2China Kangtai Cactus Biotech Announces Record Second Quarter Results 3